AccessBio Rapid Antibody Test
The CareStart™ COVID-19 IgM/IgG is intended for use as an aid in identifying and monitoring individuals previous infection history and immune response to COVID-19. This rapid test detects and differentiates IgM/IgG antibodies specific to SARS-CoV-2.
FDA EUA
Yes
Results
10 minutes
Type
Finger Prick